Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Ep 121: OMI/NOMI: A Paradigm Shift in Myocardial Infarction Diagnosis
Added: 7 months ago
In this week's episode of Parallax, host Dr Ankur Kalra engages in a thought-provoking discussion with Dr Stephen Smith, a pioneer in electrocardiography and myocardial infarction diagnosis. They delve into the groundbreaking OMI/NOMI paradigm (Occlusion MI vs Non-Occlusion MI), challenging the traditional STEMI vs non-STEMI terminology that has long been the cornerstone of acute coronary… View more

Prevention & Chronic Conditions

MI/ACS
EP 103: CCS-AMI: New Classification for Acute Myocardial Infarction with Dr Kumar
Author(s): Ankur Kalra , Andreas Kumar Added: 1 year ago
On October 28th, 2023, the Canadian Cardiovascular Society (CCS) released a new classification system for acute atherothrombotic myocardial infarction (MI) based on stages of tissue injury severity (CCS-AMI). This expert consensus is the result of decades of data on acute MI with reperfusion therapy. Dr Ankur Kalra is joined this week on Parallax by Dr Andreas Kumar, Chairperson of the Writing… View more

Imaging & Diagnostics

MI/ACS
TCT 23: PICSO-AMI-I: Pressure Controlled Intermittent Coronary Sinus Occlusion in Acute Myocardial Infarction.
Author(s): Giovanni Luigi Di Maria Added: 1 year ago
TCT 23 - We are joined by Dr Giovanni Luigi Di Maria (John Radcliffe Hospital, UK) to discuss the findings of the PICSO-AMI-I study (NCT04958421), sponsored by Miracor Medical. The PICSO-AMI-I study aimed to assess the safety and feasibility of pressure-controlled intermittent coronary sinus occlusion (PiCSO) in patients with ST-elevation myocardial infarction (MI), presenting with TIMI 0 or 1… View more

Intervention
The WICD-MI Study
Author(s): Mathieu Echivard Added: 3 weeks ago
ESC HFA 25 - The WICD-MI study finds heart failure to be frequent in patients with persistent left ventricular dysfunction after acute myocardial infarction.We are joined onsite by Dr Mathieu Echivard (University Hospital of Nancy, Nancy, FR) to discuss key findings from a study investigating heart failure events in patients with persistent left ventricular dysfunction after acute myocardial… View more

Heart Failure

MI/ACS
ESC 23 Late-Breaker Discussion: The RECORD MI Registry
Author(s): Harriette Van Spall , Javed Butler Added: 1 year ago
ESC 23 - Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Javed Butler (University of Mississippi Medical Center, US) to discuss the findings from the RECORD MI Registry. Recurrent myocardial infarction (MI) and new onset heart failure (HF) are major adverse complications in patients post-MI. Advances have been made for systems of care, coronary… View more

Heart Failure

Prevention & Chronic Conditions
ACC 24 Late-Breaker Discussion: The EMPACT-MI Trial
Author(s): Harriette Van Spall , Javed Butler Added: 1 year ago
ACC.24 — Join Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA), and Principal Investigator, Dr Javed Butler (University of Mississippi Medical Center, US), as they discuss the key findings from the EMPACT-MI trial (Boehringer Ingelheim)(NCT04509674).In this multicentre, randomised, parallel group, double-blind placebo-controlled superiority trial, investigators evaluated the… View more

Heart Failure

MI/ACS
ESC HFA 25: SCD-PROTECT
Author(s): Johann Bauersachs Added: 3 weeks ago
ESC HF 25 - SCD-PROTECT shows high risk of sudden cardiac arrest (SCA) and sudden cardiac death (SCD) during early medical therapy optimization for reduced LVEF in patients with new non-ischemic cardiomyopathy or MI/CAD.Prof Johann Bauersachs (Hannover Medical School, Hannover, DE) discusses findings from the SCD–PROTECT study, an investigation of sudden cardiac arrest in patients with newly… View more

Heart Failure

MI/ACS
Oxidative Stress Genes Predict Survival in STEMI
Author(s): Shuo-wen Sun , Xing-jie Wang , Ruo-chen Yan , et al Added: 1 month ago

MI/ACS

Prevention & Chronic Conditions
ESC 24 Hot Line Discussion: The AβYSS Trial
Author(s): Harriette Van Spall , Prof. Johanne Silvain Added: 9 months ago
ESC Congress 2024 — The interruption of beta blocker treatment was not non-inferior to a strategy of βB continuation.Host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) sits down with investigator, Prof Johanne Silvain(Pitié-Salpêtrière University Hospital, Paris, FR) to discuss key results from the AβYSS trial (NCT03498066; Assistance Publique - Hôpitaux de Paris).The ABYSS trial… View more

MI/ACS
Chelation Therapy in Post-MI Pts with Diabetes: TACT2
Author(s): Gervasio L Lamas Added: 1 year ago
ACC 24 - In this video, Dr Gervasio L Lamas (Mount Sinai Medical Center, US) joins us onsite to discuss the findings from the TACT2 study of chelation therapy in post-myocardial infarction patients with diabetes (NCT02733185).The Trial to Assess Chelation Therapy 2 (TACT2) study is a randomized, double blind factorial clinical trial, aiming to determine if chelation-based strategy increases the… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic